| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $106.9M | +9.8% |
| Cost of Revenue | $12.8M | +9.6% |
| Gross Profit | $94.2M | +9.8% |
| R&D Expense | $71.6M | -1.5% |
| SG&A Expense | $16.9M | +13.2% |
| Operating Income | -$7.5M | +44.0% |
| Pre-tax Income | -$2.8M | +66.4% |
| Income Tax | $6.0M | -41.1% |
| Net Income | -$8.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.5M | -20.6% |
| Short-term Investments | $312K | -23.2% |
| Accounts Receivable | $37.2M | +22.8% |
| Current Assets | $216.3M | +3.3% |
| Total Assets | $308.9M | +1.6% |
| Current Liabilities | $30.5M | +13.5% |
| Stockholders' Equity | $266.6M | +0.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.5M | +154.8% |
| Capital Expenditures | $3.0M | +2.5% |
| Investing Cash Flow | -$2.4M | -122.6% |
| Financing Cash Flow | -$5.6M | -101.2% |
| Free Cash Flow | $516K | +105.6% |
| +26.0% |
| EPS (Basic) | -$0.37 | +27.5% |
| EPS (Diluted) | -$0.37 | +27.5% |